Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Selective induction of matrix metalloproteinases by Borrelia burgdorferi via toll-like receptor 2 in monocytes.

Gebbia JA, Coleman JL, Benach JL.

J Infect Dis. 2004 Jan 1;189(1):113-9. Epub 2003 Dec 22.

PMID:
14702161
2.

Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi.

Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ.

J Immunol. 2002 Jan 1;168(1):348-55.

3.

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.

Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G.

Gastroenterology. 2004 Nov;127(5):1513-24.

PMID:
15521019
4.

Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells.

Parker LC, Whyte MK, Vogel SN, Dower SK, Sabroe I.

J Immunol. 2004 Apr 15;172(8):4977-86.

5.

Induction of nuclear factor- kappa B and c-Jun/activator protein-1 via toll-like receptor 2 in macrophages by antimycotic-treated Candida albicans.

Roeder A, Kirschning CJ, Schaller M, Weindl G, Wagner H, Korting HC, Rupec RA.

J Infect Dis. 2004 Oct 1;190(7):1318-26. Epub 2004 Aug 25.

PMID:
15346344
6.

Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice.

Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, Medzhitov R, Fikrig E, Flavell RA.

Nat Med. 2002 Aug;8(8):878-84. Epub 2002 Jul 1.

PMID:
12091878
7.

Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk.

LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, Griffin GE, Ferrara P, Schiffrin EJ, Morgan BP, Labéta MO.

J Immunol. 2003 Dec 15;171(12):6680-9.

8.

Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans.

Quesniaux VJ, Nicolle DM, Torres D, Kremer L, Guérardel Y, Nigou J, Puzo G, Erard F, Ryffel B.

J Immunol. 2004 Apr 1;172(7):4425-34.

9.

Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.

Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, van Krieken JH, Hartung T, Adema G, Kullberg BJ.

J Immunol. 2004 Mar 15;172(6):3712-8.

10.
12.
13.
14.
15.
16.

Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.

Köllisch G, Kalali BN, Voelcker V, Wallich R, Behrendt H, Ring J, Bauer S, Jakob T, Mempel M, Ollert M.

Immunology. 2005 Apr;114(4):531-41.

20.

Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.

Knapp S, Wieland CW, van 't Veer C, Takeuchi O, Akira S, Florquin S, van der Poll T.

J Immunol. 2004 Mar 1;172(5):3132-8.

Supplemental Content

Support Center